Haematopoietic progenitors and signal transduction in polycythaemia vera and primary thrombocythaemia.
While significant progress has been made in understanding the cellular defect and molecular basis of polycythaemia vera (PV), elucidation of the primary mutation leading to PV remains elusive. While clinically useful, the PV diagnostic criteria put forward by the Polycythemia Vera Study Group are not based on the pathophysiology of this disorder and in some instances may lead to false diagnosis or may not be sufficient to diagnose an early PV. In diagnostically unclear situations, clinical and laboratory findings must take into account the acquired nature of PV, its clonality, and the presence of endogenous erythroid colony formation in serum-containing media. It is likely that other simpler assays may be developed based on the rapidly emerging knowledge of the cellular pathology of PV. Several intriguing observations of abnormalities pertaining to the erythroid signal transduction have been recently reported; these remain to be validated in other laboratories and to be proven specific for PV. The clinical concept of primary thrombocythaemia (PT) lags behind what we know about PV. While the diagnosis of PT is still based on the exclusion of other known causes of thrombocytosis, new knowledge is emerging. Recent clonality studies of a large number of PT females show that the majority are clonal. It is our belief that thrombocythaemic subjects who are not found to be clonal are those with secondary thrombocytosis. Multiple in vitro-based assays of megakaryocytic and erythroid progenitors have been developed and conflicting data published. It is likely that standardized assays of megakaryocytic progenitors will soon become available and a reproducible PT specific defect will be found. Such a specific test would be of immense diagnostic value in this most elusive of all myeloproliferative disorders.
Kralovics
R
R
Division of Hematology/Oncology, University of Alabama at Birmingham 35294, USA.
Prchal
J T
JT
D002478:Cells, Cultured / Q000187:drug effects; D002999:Clone Cells / Q000473:pathology; D003114:Colony-Forming Units Assay; D016895:Culture Media, Serum-Free / Q000494:pharmacology; D016207:Cytokines / Q000494:pharmacology; D015672:Erythroid Precursor Cells / Q000473:pathology; D005260:Female; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology; D008297:Male; D011087:Polycythemia Vera / Q000175:diagnosis / Q000378:metabolism / Q000473:pathology*; D015398:Signal Transduction / Q000502:physiology*; D013920:Thrombocythemia, Essential / Q000175:diagnosis / Q000378:metabolism / Q000473:pathology*
D016895:Culture Media, Serum-Free; D016207:Cytokines; D007334:Insulin-Like Growth Factor I